Today's Hours: 8:00am - 10:00pm

Search

Did You Mean:

Search Results

  • Book
    editors, Mark D. Duncan, MD, Resident Physician, Department of Medicine, UCLA Medical Center, ... Show More Los Angeles, California, Lance W. Chapman, MD, MBA, Resident Physician, Department of Dermatology, UC Irvine Medical Center, Irvine, California, Minesh P. Shah, MD, MPH, Assistant Professor, Division of General Internal Medicine, University of Illinois at Chicago, Chicago, Illinois.
    Contents:
    Cardiology
    Pulmonology
    Nephrology
    Gastroenterology
    Endocrine and metabolic disorders
    Infectious diseases
    Hematology and oncology
    Neurology
    Rheumatology
    Dermatology
    General medicine
    Practice examination
    Shelf pearls.
  • Article
    Alomar A, Giménez-Camarasa JM, de Moragas JM.
    Arch Dermatol. 1978 Sep;114(9):1316-9.
    Levamisole hydrochloride, a nonspecific immunostimulant, was given to 30 children with atopic dermatitis (AD) in a double-blind manner during an eight-month period. Clinical course findings, including intradermal reactions to tuberculin, candidin, and streptokinase-streptodernase; sensitization to dinitrochlorobenzene; periphal blood T- and B-lymphocytes; in vitro lymphocyte transformation with phytohemagglutinin; and serum levels of IgM, IgG, IgA, and IgE, were noted every two months. Fifteen children completed the study. Neither the clinical course nor the immunologic values showed substantial differences between the levamisole-treated and the placebo group. Our experience with levamisole in AD is disappointing.
    Digital Access Access Options